The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient (original) (raw)
Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study
Dimas N
American Journal of Medicine, 1996
View PDFchevron_right
Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis
Pierce Geoghegan
Expert review of anti-infective therapy, 2018
View PDFchevron_right
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
Joel Singer
European Journal of Clinical Microbiology & Infectious Diseases, 1997
View PDFchevron_right
A Randomized and Blinded Multicenter Trial of High‐Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects
Jeannette Lee
Clinical Infectious Diseases, 2003
View PDFchevron_right
Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: …
Omrum Uzun
The American journal of …, 1996
View PDFchevron_right
Fluconazole therapy for treatment of invasive candidiasis in Intensive Care patients. Is it still valid from a pharmacological point of view
Paolo Mura
2014
View PDFchevron_right
Empirical treatment of candidemia in intensive care units: Fluconazole or broad-spectrum antifungal agents?
Teresa Peláez
Medical Mycology, 2009
View PDFchevron_right
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
Thomas Bregenzer
The Journal of infection, 2018
View PDFchevron_right
In Vitro Pharmacodynamic Characteristics of Amphotericin B, Caspofungin, Fluconazole, and Voriconazole against Bloodstream Isolates of Infrequent Candida Species from Patients with Hematologic Malignancies
Domenico Dantonio
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Michele Mussap
Journal of Antimicrobial Chemotherapy, 2009
View PDFchevron_right
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
Eric Bow
The American Journal of Medicine, 1991
View PDFchevron_right
Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients
Marie Diener-West
Annals of Surgery, 2001
View PDFchevron_right
Timely selection of adequate antifungal therapy for candidemia in the critically ill: Donʼt let the yeast rise!*
Alberto Corona
Critical Care Medicine, 2008
View PDFchevron_right
Epidemiology, risk factors, and therapy of candidemia in pediatric hematological patients
Simone Cesaro
View PDFchevron_right
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
J. Kosterink
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Failure of Systemic Empirical Treatment with Amphotericin B to Prevent Candidemia in Neutropenic Patients with Cancer
A. Reboli
Clinical Infectious Diseases, 1996
View PDFchevron_right
Nosocomial fungal infections: candidemia
Andreas Voss
Diagnostic Microbiology and Infectious Disease, 1999
View PDFchevron_right
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models
Mahmoud Ghannoum
1997
View PDFchevron_right
Candida Infections in Surgical Patients Dose Requirements and Toxicity of Amphotericin B
Richard Simmons
Annals of Surgery, 1982
View PDFchevron_right
Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children*
Shai Ashkenazi
Pediatric Critical Care Medicine, 2006
View PDFchevron_right
Treatment of Severe Candida Infections in High-Risk Patients in Germany: Consensus Formed by a Panel of Interdisciplinary Investigators
Arno Schmalreck
European Journal of Clinical Microbiology & Infectious Diseases, 2002
View PDFchevron_right
Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia
Mukesh Patel
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Incidence of candidaemia and antifungal sensitivity in critically ill patients
Vincenzo Vullo, Maria Mascellino
View PDFchevron_right
Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
M. Van Driel
International Journal of Infectious Diseases, 2019
View PDFchevron_right